The Value of GLP-1s: Reality Check

The demand for GLP-1 prescriptions is skyrocketing, with a 259% increase in prescriptions between 2021 and 2022 alone.  

A recent survey shows 81% of HR decision-makers feel that their employees would be interested in GLP-1 medications.

Therefore, Employers are implementing plans to ensure that their population can access medications, costs are measured, and compliance is met. A recent survey found that U.S. employers covering weight-loss drugs could nearly double in 2024 totaling around $9,000 per employee per year.  

With so many digital health solutions in the market today, employers have a lot to consider. When it comes to a partner for anti-obesity and diabetes medication, here’s what you want to look for:

• Proven experience with behavior change
• High level of data transparency
• Flexibility to support any scenario